CTAD — Clinical Trials on Alzheimer's disease 2022

November 29, 2022
December 2, 2022

Ardea Outcomes will be attending CTAD 2022 in San Francisco, CA.

The Clinical Trials on Alzheimer's Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.

Conference Website